Summary
- Current Price
- As of today, LEXX price is $0.67, down -0.89% in the most recent trading session on
- Current Price All-Time High
- LEXX price is currently -94.65% below its historical high of $12.50 set on
- Market Cap
- LEXX current market cap is $17M, down -18.55% year-over-year
- PE Ratio
- LEXX PE ratio is unknown
- Revenue
- LEXX current annual revenue is $705.90K, up +52.04% year-over-year
- Next Earnings
- As of today, the next earnings release for LEXX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Lexaria Bioscience Corp. |
| Ticker | NASDAQ: LEXX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | lexariabioscience.com |
| Employees | 7 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.67 | ||
| Price, 1D Change | -0.89% | |
| $17M | ||
| - | ||
| - | ||
| 0.95 | ||
| $706K | ||
| Revenue, 1Y Change | +52.04% | |
| -$0.66 | ||
| EPS, 1Y Change | -41.30% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | LXRP | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.66 | ||
| EPS Estimate | N/A | -$0.26 |
| EPS Est. Change | N/A | +60.68% |
| $705.90K | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.67 | ||
| Price Target | - | $3.75 |
| Price Tgt. Change | - | +461.04% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.47 | - | |
| -$0.68 | -$0.66 | +2.28% | |
| -$0.26 | N/A | +60.68% | |
| -$0.31 | N/A | +53.12% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $403.67K | $464.30K | +15.02% | |
| $669.00K | $705.90K | +5.52% | |
| - | N/A | - | |
| $1.40M | N/A | +98.75% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -35.73% | ||
| -48.98% | ||
| -18.55% | ||
| +111.29% | ||
| +52.04% | ||
| +176.39% | ||
| -41.30% | ||
| +46.46% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.67 | ||
| $0.88 | ||
| SMA 200 vs Price | +32.39% | |
| $0.82 | ||
| SMA 50 vs Price | +22.16% | |
| 0.95 | ||
| $0.09 | ||
| 35.89 | ||
| 125.25% | ||
| 102.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $705.90K | ||
| -$0.66 | ||
| $587.40K | ||
| 83.21% | ||
| -$11.63M | ||
| -1,648.02% | ||
| -$11.91M | ||
| -1,687.41% | ||
| -$11.52M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 2.32 | ||
| 2.32 | ||
| - | ||
| 3 | ||
| -23.42 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 45.02 | ||
| 2.51 | ||
| -1.24 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $2.99M | ||
| $1.97M | ||
| $4.18M | ||
| $3.47M | ||
| $1.57M | ||
| $1.49M | ||
| $109.30K | ||
| $30.40K | ||
| $569.80K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $12.61M | ||
| $12.22M | ||
| $118.60K | ||
| $4.35M | ||
| $115.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$10.45M | ||
| -$243.00K | ||
| $6.05M | ||
| $99.80K | ||
| -$10.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Maxim Group | → | |
| Maxim Group |
Analyst sentiment
Institutional ownership
Screeners with LEXX
FAQ
What is the ticker symbol for Lexaria Bioscience Corp.?
The ticker symbol for Lexaria Bioscience Corp. is NASDAQ:LEXX
Does Lexaria Bioscience Corp. pay dividends?
No, Lexaria Bioscience Corp. does not pay dividends
What sector is Lexaria Bioscience Corp. in?
Lexaria Bioscience Corp. is in the Healthcare sector
What industry is Lexaria Bioscience Corp. in?
Lexaria Bioscience Corp. is in the Biotechnology industry
What country is Lexaria Bioscience Corp. based in?
Lexaria Bioscience Corp. is headquartered in Canada
When did Lexaria Bioscience Corp. go public?
Lexaria Bioscience Corp. initial public offering (IPO) was on January 12, 2021
Is Lexaria Bioscience Corp. in the S&P 500?
No, Lexaria Bioscience Corp. is not included in the S&P 500 index
Is Lexaria Bioscience Corp. in the NASDAQ 100?
No, Lexaria Bioscience Corp. is not included in the NASDAQ 100 index
Is Lexaria Bioscience Corp. in the Dow Jones?
No, Lexaria Bioscience Corp. is not included in the Dow Jones index
When was Lexaria Bioscience Corp. last earnings report?
Lexaria Bioscience Corp.'s most recent earnings report was on January 9, 2026
When does Lexaria Bioscience Corp. report earnings?
The date for Lexaria Bioscience Corp.'s next earnings report has not been announced yet
Data Sources & References
- LEXX Official Website lexariabioscience.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1348362/000164033425002225/0001640334-25-002225-index.htm
- LEXX Profile on Yahoo Finance finance.yahoo.com/quote/LEXX
- LEXX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lexx